Quantum Private Wealth, LLC Oncternal Therapeutics, Inc. Transaction History

Quantum Private Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$0.29 - $0.48 $869 - $1,440	3,000 Added 0.66%	459,187 $137,000
Q2 2023 Jul 27, 2023	SELL	$0.28 - $0.79 $364 - $1,027	-1,300 Reduced 0.28%	456,187 $155,000
Q1 2023 Apr 19, 2023	SELL	$0.63 - $1.3 $4,327 - $8,929	-6,869 Reduced 1.48%	457,487 $361,000
Q4 2022 Jan 20, 2023	BUY	$0.86 - $22.2 $2,580 - $66,600	3,000 Added 0.65%	464,356 $0
Q3 2022 Nov 01, 2022	BUY	$0.83 - $17.8 $4,731 - $101,460	5,700 Added 1.25%	461,356 $411,000
Q2 2022 Aug 17, 2022	BUY	$0.7 - $1.56 $7,349 - $16,380	10,500 Added 2.36%	455,656 $505,000
Q1 2022 May 27, 2022	BUY	$1.37 - $2.43 $6,850 - $12,150	5,000 Added 1.14%	445,156 $618,000
Q4 2021 May 26, 2022	BUY	$2.27 - $4.39 $999,154 - $1.93 Million	440,156 New	440,156 $999,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Quantum Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantum Private Wealth, LLC with notifications on news.